Rare diseases
Investigational molecules
Locations
Study of Darovasertib for Patients with Localized Uveal Melanoma
FranceStudy on Psilocybin for Patients with Alcohol Use Disorder and Depression Symptoms
FranceStudy on Ponatinib for Patients with Chronic Myelogenous Leukemia in Molecular Response
SpainStudy on Briquilimab for Adults with Chronic Inducible Urticaria Unresponsive to H1-Antihistamines
GermanyStudy on MK-6194 for Treating Adults with Non-Segmental Vitiligo
BelgiumStudy on the Safety of Human Serum Albumin and Enoxaparin in Patients with Decompensated Cirrhosis at High Risk of Poor Outcome
FranceStudy on the Effects of EP262 for Adults with Chronic Spontaneous Urticaria
GermanyStudy of Pembrolizumab with Drug Combination for Patients with Advanced Non-Small Cell Lung Cancer
HungaryStudy of Pembrolizumab and Enzalutamide in Patients with Metastatic Hormone-Sensitive Prostate Cancer
DenmarkStudy on Pembrolizumab and Lenvatinib for Patients with Pre-Treated Thymic Carcinoma and B3-Thymoma
FranceStudy of Sacituzumab Govitecan for Patients with Advanced or Metastatic Bladder Cancer
FranceStudy of Pembrolizumab, Cisplatin, and Gemcitabine for Patients with Muscle-Invasive Bladder Cancer Eligible for Cisplatin Treatment
BelgiumTell us about your condition – we search every trial in Europe and connect you with the right site.
